Intercure (INCR) vs Rafael (RFL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Rafael (RFL) has outperformed Intercure (INCR) over the past year, gaining 9.6% versus a loss of 37.5%. Over five years, INCR leads with a -85.8% price change compared with -95.1% for RFL. Rafael is the larger company by market cap ($82.2 million vs $75.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INCR | RFL |
|---|---|---|
| Share price | $5.02 | $1.58 |
| Market cap | $75.32M | $82.16M |
| 1-day change | 0.00% | +6.76% |
| YTD return | +10.55% | +25.42% |
| 1-year return | -37.52% | +9.63% |
| 5-year return | -85.81% | -95.09% |
| EPS (TTM) | $-0.95 | $-0.72 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.40 | $3.96 |
| 52-week low | $3.40 | $1.12 |
| Distance from 52-week high | -40.24% | -60.10% |
| Average volume | 21.73K | 159.84K |
| Shares outstanding | 15.00M | 51.21M |
| Employees | 285 | 21 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RFL has outperformed INCR by 47.1 percentage points over the past year.
About Intercure
INCR stock →InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Health Care · Biotechnology: Pharmaceutical Preparations · 285 employees
About Rafael
RFL stock →Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel.
Health Care · Biotechnology: Pharmaceutical Preparations · 21 employees
INCR vs RFL FAQ
Which is bigger, Intercure or Rafael?
Rafael (RFL) is larger, with a market capitalization of $82.16M compared with $75.32M for Intercure (INCR).
Which stock has performed better over the past year, INCR or RFL?
RFL returned +9.63% over the past 12 months, compared with -37.52% for INCR (price return, excluding dividends). Past performance does not predict future results.
Are Intercure and Rafael in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.